Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

por Bykerk, V P, Cush, J, Winthrop, K, Calabrese, L, Lortholary, O, de Longueville, M, van Vollenhoven, R, Mariette, X
Publicado 2015

The Relationship Between Function and Disease Activity as Measured by the HAQ and DAS28 Varies Over Time and by Rheumatoid Factor Status in Early Inflammatory Arthritis (EIA). Resu...

por Boyd, Tristan A, Bonner, A, Thorne, C, Boire, G, Hitchon, C, Haraoui, B.P, Keystone, E.C, Bykerk, V.P, Pope, J.E
Publicado 2013

Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort

por Ellingwood, L., Schieir, O., Valois, M. F., Bartlett, S. J., Bessette, L., Boire, G., Hazlewood, G., Hitchon, C., Keystone, E. C., Tin, D., Thorne, C., Bykerk, V. P., Pope, J. E.
Publicado 2019

Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis

por Kuriya, B., Schieir, O., Valois, M. F., Pope, J. E., Boire, G., Bessette, L., Hazlewood, G., Thorne, J. C., Tin, D., Hitchon, C., Bartlett, S., Keystone, E. C., Bykerk, V. P., Barra, L.
Publicado 2019

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from...

por Emery, P, Bingham, C O, Burmester, G R, Bykerk, V P, Furst, D E, Mariette, X, van der Heijde, D, van Vollenhoven, R, Arendt, C, Mountian, I, Purcaru, O, Tatla, D, VanLunen, B, Weinblatt, M E
Publicado 2017